Kerri A. Ohman

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. William G. Hawkins · 2 shared papers, 2016–2017 · strength 0.12
   • Paper Interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: long-term follow-up. DOI 10.1016/j.hpb.2017.01.012↗
   • Paper Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic canc… DOI 10.18632/oncotarget.9551↗
2. David C. Linehan · 1 shared paper, 2017 · strength 0.07
   • Paper Interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: long-term follow-up. DOI 10.1016/j.hpb.2017.01.012↗
3. Marcus Chuan Beng Tan · 1 shared paper, 2017 · strength 0.07
   • Paper Interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: long-term follow-up. DOI 10.1016/j.hpb.2017.01.012↗
4. Steven M. Strasberg · 1 shared paper, 2017 · strength 0.07
   • Paper Interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: long-term follow-up. DOI 10.1016/j.hpb.2017.01.012↗
5. Ryan C Fields · 1 shared paper, 2017 · strength 0.07
   • Paper Interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: long-term follow-up. DOI 10.1016/j.hpb.2017.01.012↗
6. Dirk M. Spitzer · 1 shared paper, 2016 · strength 0.05
   • Paper Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic canc… DOI 10.18632/oncotarget.9551↗
7. Timothy M. Nywening · 1 shared paper, 2016 · strength 0.05
   • Paper Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic canc… DOI 10.18632/oncotarget.9551↗
8. Yassar M. Hashim · 1 shared paper, 2016 · strength 0.05
   • Paper Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic canc… DOI 10.18632/oncotarget.9551↗
9. David Arthur Tuveson · 1 shared paper, 2016 · strength 0.05
   • Paper Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic canc… DOI 10.18632/oncotarget.9551↗
10. Hervé Tiriac · 1 shared paper, 2016 · strength 0.05
    • Paper Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic canc… DOI 10.18632/oncotarget.9551↗
11. David G DeNardo · 1 shared paper, 2016 · strength 0.05
    • Paper Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic canc… DOI 10.18632/oncotarget.9551↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.